Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis.

Clicks: 359
ID: 113445
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #5 of 39 articles by views in integrative medicine research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lianhuaqingwen (LH) has been proven effective for influenza. However, the promotion of LH for the treatment of patients with COVID-19 remains controversial. Therefore, our study aimed to assess the efficacy and safety of Lianhuaqingwen (LH) in treating patients with COVID-19 by a systematic review and meta-analysis.We conducted the literature search using six electronic databases from December 1, 2019, to June 2, 2020. Cochrane Risk of Bias tool has been used to assess the quality of randomized controlled trials. Newcastle-Ottawa Scale has been used to assess the quality of case control studies. Agency for Healthcare Research and Quality checklist has been used to assess the quality of case series. All analyses were conducted by RevMan 5.3. For outcomes that could not be meta-analyzed were performed a descriptive analysis.Eight studies with 924 patients were included. Three studies are RCTs, three are case control studies, and two are case series. The quality of the included studies was poor. Compared with patients treated by conventional treatment, patients treated by LH combined with conventional treatment have a higher overall effective rate (RR = 1.16, 95%CIs: 1.04∼1.30,  = 0.01) and CT recovery rate (RR=1.21, 95%CIs: 1.02∼1.43,  = 0.03). Patients of LH groups have a lower incidence of diarrhea (5.6% vs.13.4%), and have statistically significant ( = 0.026). But the rate of abnormal liver function in the combined medication group is higher than that in the single LH group.LH combined with conventional treatment seems to be more effective for patients with mild or ordinary COVID-19.
Reference Key
liu2020efficacyintegrative Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Liu, Ming;Ya, Gao;Yuan, Yuan;Yang, Kelu;Shi, Shuzhen;Tian, Jinhui;Zhang, Junhua;
Journal integrative medicine research
Year 2020
DOI
10.1016/j.imr.2020.100644
URL
Keywords
meta-analysis systematic review herbal medicine covid-19 lianhuaqingwen

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.